lobbying_activities: 2461078
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2461078 | d3ab6c0d-d918-4163-bf7d-33fa6ce76956 | Q2 | EAST END GROUP, LLC | 400646949 | CORBUS PHARMACEUTICALS HOLDINGS, INC | 2020 | second_quarter | HCR | Drug Enforcement Agency scheduling of Cannabinoids. Legislative and regulatory issues related to Food and Drug Administration review of scheduled compounds. | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2020-07-03T12:06:36.267000-04:00 |